Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 2,580.83 Million | USD 4,072.87 Million | CAGR at 5.20% | 2023 |
According to the report published by Zion Market Research, the global Frozen Shoulder Treatment Market size was valued at USD 2,580.83 Million in 2023 and is predicted to reach USD 4,072.87 Million by the end of 2032. The market is expected to grow with a CAGR of 5.20% during the forecast period. The report analyzes the global Frozen Shoulder Treatment Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Frozen Shoulder Treatment Market industry.
Frozen shoulder is the common term for adhesive capsulitis and this is the shoulder condition that restricts the motion. In frozen shoulder condition, the tissues of the shoulder joint has become tight and thick and scar tissue is created within a specified time. The most common symptoms of frozen shoulder are stiffness, swelling, and pain. In addition to this, reduction in the shoulder movement is predicted to increase the stiffness in shoulders. An elongated period of inactivity as a result of injury, surgery, and illness also increases susceptibility to inflammation & adhesion that are bands of stiff tissues.
Surge in the aging populace prone to frozen shoulder is predicted to create massive scope for the market over the ensuing years. According to NIH (National Institutes of Health), the population with an age of 65 years and more across the U.S. is predicted to double over the coming three decades by end of 2050. Reportedly, the population aging 80 and more is set to triple by 2050 in the U.S. For the record, the population over the age of 80 years will quadruple by the end of 2050. In this way, the growth of the market is likely to be leaps & bounds over the forecast timespan.
Furthermore, shoulder injuries are likely to result in frozen shoulder, thereby driving the business growth over the forecast timespan. Apparently, high risk of heart disorders and diabetes is likely to result in the frozen shoulder, thereby steering the expansion of frozen shoulder treatment industry over the forthcoming years. Massive investments in research activities pertaining to frozen shoulder therapy are projected to create lucrative growth avenues for the market over the forecast timeline.
The global frozen shoulder treatment market can be classified based on treatment type, route of administration, end-user, and region.
In terms of treatment type, the frozen shoulder treatment industry is fragmented into medication, surgery, physical treatment, and joint distension.
On the basis of route of administration, the market is segregated into Oral and Parental.
End-User wise, the market is divided into Hospitals, Homecare, and Specialty Clinics. Region-wise, the market can be divided into the Middle East and Africa, North America, Latin America Asia Pacific, and Europe.
Report Attributes | Report Details |
---|---|
Report Name | Frozen Shoulder Treatment Market Research Report |
Market Size in 2023 | USD 2,580.83 Million |
Market Forecast in 2032 | USD 4,072.87 Million |
Growth Rate | CAGR of 5.20% |
Number of Pages | 201 |
Key Companies Covered | GlaxoSmithKline plc, Vintage Pharma, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, and Contract Pharmacal Corp. |
Segments Covered | By treatment type, By route of administration, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is projected to contribute majorly towards overall market earnings during the forecast timespan. The growth of the regional market over the estimated timeline can be credited to rise in the research activities along with launching of technologically advanced items by the giant firms. Apart from this, advanced treatment procedures for providing quick relief for the subjects suffering from frozen shoulder will prompt the regional market growth over the forecast timespan. Apparently, presence of giant firms in the countries like the U.S. and Canada will promote the regional growth trends.
Key participants profiled in the study include:
By treatment type
By route of administration
By end-user
FrequentlyAsked Questions
Surge in the aging populace prone to frozen shoulder is predicted to create massive scope for the market over the ensuing years. According to NIH (National Institutes of Health), the population with an age of 65 years and more across the U.S. is predicted to double over the coming three decades by end of 2050. Reportedly, the population aging 80 and more is set to triple by 2050 in the U.S. For the record, the population over the age of 80 years will quadruple by the end of 2050. In this way, the growth of the market is likely to be leaps & bounds over the forecast timespan. Furthermore, shoulder injuries are likely to result in frozen shoulder, thereby driving the business growth over the forecast timespan. Apparently, high risk of heart disorders and diabetes is likely to result in the frozen shoulder, thereby steering the expansion of frozen shoulder treatment industry over the forthcoming years.
The key players profiled in the report include GlaxoSmithKline plc, Vintage Pharma, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, and Contract Pharmacal Corp.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed